SCHEMBL2453111

SCHEMBL2453111

COC(=O)CC(C(=O)OC)N1C(=O)CCC1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39
ALDH1A1 P00352 3/20 0.38
PKM P14618 1/20 0.38
BRD4 O60885 1/20 0.35
SLC1A2 P43004 2/20 0.34
TNF P01375 3/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
MAPT P10636 2/20 0.32
RAB9A P51151 1/20 0.32
THRB P10828 1/20 0.32
TSHR P16473 1/20 0.31
HTT P42858 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CHRM5 P08912 1/20 0.31
CHRM1 P11229 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2453112 0.86 KMT2A (0.49) KMT2AATMALDH1A1PKMSLC1A2
SCHEMBL15511368 0.82 CA1 (0.41) KMT2AATMALDH1A1PKMSLC1A2
SCHEMBL1251744 0.81 ALDH1A1 (0.41) KMT2AATMALDH1A1PKMBRD4
SCHEMBL2458117 0.76 MAPT (0.46) KMT2AATMALDH1A1PKMMAPT
SCHEMBL1251745 0.74 ALDH1A1 (0.41) KMT2AATMALDH1A1PKMSLC1A2
SCHEMBL17706710 0.74 L3MBTL1 (0.43) KMT2AALDH1A1MAPTRAB9ATSHR
SCHEMBL11567612 0.74 L3MBTL1 (0.43) KMT2AALDH1A1MAPTRAB9ATSHR
SCHEMBL28918361 0.73 MAPT (0.38) KMT2AATMALDH1A1PKMMAPT
SCHEMBL9650037 0.73 ALDH1A1 (0.70) KMT2AATMALDH1A1PKMSLC1A2
SCHEMBL43936 0.72 ALDH1A1 (0.49) KMT2AATMALDH1A1PKMSLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2955233-A1 Proteinase K inhibitors, methods and compositions therefor Life Technologies Corporation (US) 2015-12-16 EP disclosed
US-9114104-B2 Proteinase K inhibitors, methods and compositions therefor Life Technologies Corporation (US) 2015-08-25 US disclosed
EP-2367954-B1 PROTEINASE K INHIBITORS, METHODS AND COMPOSITIONS THEREFOR LIFE TECHNOLOGIES CORP (US) 2015-02-18 EP disclosed
US-20130004941-A1 PROTEINASE K INHIBITORS, METHODS AND COMPOSITIONS THEREFOR Life Technologies Corporation (US) 2013-01-03 US disclosed
US-8211637-B2 Proteinase K inhibitors, methods and compositions therefor Life Technologies Corporation (US) 2012-07-03 US disclosed
EP-2367954-A1 PROTEINASE K INHIBITORS, METHODS AND COMPOSITIONS THEREFOR Life Technologies Corporation (US) 2011-09-28 EP disclosed
WO-2010071833-A1 PROTEINASE K INHIBITORS, METHODS AND COMPOSITIONS THEREFOR Life Technologies Corporation (US) 2010-06-24 WO disclosed
US-20100159482-A1 PROTEINASE K INHIBITORS, METHODS AND COMPOSITIONS THEREFOR Life Technologies Corporation (US) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130004941-A1 PROTEINASE K INHIBITORS, METHODS AND COMPOSITIONS THEREFOR CPSF7, CTSL, CTSK KMT2A 1951/4885ATM 3957/4885ALDH1A1 3836/4885
US-20100159482-A1 PROTEINASE K INHIBITORS, METHODS AND COMPOSITIONS THEREFOR CPSF7, CTSL, CTSK KMT2A 1951/4885ATM 3957/4885ALDH1A1 3836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.